应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ADIL Adial Pharmaceuticals
休市中 12-12 16:00:00 EST
0.2956
-0.0015
-0.50%
盘后
0.2941
-0.0015
-0.51%
17:48 EST
最高
0.3048
最低
0.2931
成交量
26.72万
今开
0.3000
昨收
0.2971
日振幅
3.94%
总市值
709.07万
流通市值
705.86万
总股本
2,399万
成交额
7.98万
换手率
1.12%
流通股本
2,388万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Adial Pharmaceuticals 宣布进行一项约 286 万美元的认股权证诱导交易
美股速递 · 11-26
Adial Pharmaceuticals 宣布进行一项约 286 万美元的认股权证诱导交易
Adial Pharmaceuticals: 根据Eop2会议实施FDA的建议,推动Ad04进入3期开发
美股速递 · 11-14
Adial Pharmaceuticals: 根据Eop2会议实施FDA的建议,推动Ad04进入3期开发
Adial Pharmaceuticals在FDA二期临床试验结束会议获得积极反馈后发布AD04项目业务更新
美股速递 · 09-16
Adial Pharmaceuticals在FDA二期临床试验结束会议获得积极反馈后发布AD04项目业务更新
Adial Pharmaceuticals, Inc盘中异动 股价大涨6.66%
市场透视 · 09-13
Adial Pharmaceuticals, Inc盘中异动 股价大涨6.66%
Adial Pharmaceuticals获纳斯达克180个日历日延期 以重新符合最低买入价规则
美股速递 · 09-03
Adial Pharmaceuticals获纳斯达克180个日历日延期 以重新符合最低买入价规则
Adial Pharmaceuticals, Inc盘中异动 早盘股价大跌5.90%
市场透视 · 08-14
Adial Pharmaceuticals, Inc盘中异动 早盘股价大跌5.90%
Adial Pharmaceuticals, Inc盘中异动 大幅下跌5.17%
市场透视 · 08-08
Adial Pharmaceuticals, Inc盘中异动 大幅下跌5.17%
Adial Pharmaceuticals, Inc盘中异动 早盘大幅下挫5.01%报0.392美元
市场透视 · 08-07
Adial Pharmaceuticals, Inc盘中异动 早盘大幅下挫5.01%报0.392美元
Adial Pharmaceuticals, Inc盘中异动 下午盘股价大涨5.87%
市场透视 · 08-06
Adial Pharmaceuticals, Inc盘中异动 下午盘股价大涨5.87%
Adial Pharmaceuticals, Inc盘中异动 早盘股价大跌9.91%
市场透视 · 08-04
Adial Pharmaceuticals, Inc盘中异动 早盘股价大跌9.91%
Adial Pharmaceuticals, Inc盘中异动 早盘急速下跌5.06%
市场透视 · 07-31
Adial Pharmaceuticals, Inc盘中异动 早盘急速下跌5.06%
Adial Pharmaceuticals, Inc股价上涨11.21% 市值涨123.9万美元
市场透视 · 07-29
Adial Pharmaceuticals, Inc股价上涨11.21% 市值涨123.9万美元
Adial Pharmaceuticals, Inc盘中异动 股价大涨20.58%
市场透视 · 07-28
Adial Pharmaceuticals, Inc盘中异动 股价大涨20.58%
Adial Pharmaceuticals, Inc7月23日成交额为57.38万美元
市场透视 · 07-24
Adial Pharmaceuticals, Inc7月23日成交额为57.38万美元
Adial Pharmaceuticals, Inc盘中异动 快速拉升5.04%报0.425美元
市场透视 · 07-17
Adial Pharmaceuticals, Inc盘中异动 快速拉升5.04%报0.425美元
Adial Pharmaceuticals, Inc7月15日成交额为22.28万美元
市场透视 · 07-16
Adial Pharmaceuticals, Inc7月15日成交额为22.28万美元
Adial Pharmaceuticals, Inc盘中异动 股价大跌5.61%
市场透视 · 07-14
Adial Pharmaceuticals, Inc盘中异动 股价大跌5.61%
Adial Pharmaceuticals, Inc盘中异动 大幅下跌5.12%
市场透视 · 07-11
Adial Pharmaceuticals, Inc盘中异动 大幅下跌5.12%
Adial Pharmaceuticals, Inc7月10日成交额为243.63万美元
市场透视 · 07-11
Adial Pharmaceuticals, Inc7月10日成交额为243.63万美元
Adial Pharmaceuticals, Inc7月9日成交额为55.05万美元
市场透视 · 07-10
Adial Pharmaceuticals, Inc7月9日成交额为55.05万美元
公司概况
公司名称:
Adial Pharmaceuticals
所属市场:
NASDAQ
上市日期:
--
主营业务:
Adial Pharmaceuticals, Inc.于2010年11月成立为弗吉尼亚有限责任公司。该公司是一家临床阶段的生物制药公司,专注于开发治疗或预防成瘾和相关疾病的疗法。该公司的研究性新药候选药物AD04正在开发中,作为一种治疗剂,用于治疗酒精使用障碍(“AUD”)。AD04最近在一项3期临床试验中进行了研究,指定为ONWARD试验,用于对具有某些目标基因型的受试者进行AUD的潜在治疗,这些目标基因型是使用伴随诊断基因测试确定的。
发行价格:
--
{"stockData":{"symbol":"ADIL","market":"US","secType":"STK","nameCN":"Adial Pharmaceuticals","latestPrice":0.2956,"timestamp":1765573200000,"preClose":0.2971,"halted":0,"volume":267229,"hourTrading":{"tag":"盘后","latestPrice":0.2941,"preClose":0.2956,"latestTime":"17:48 EST","volume":10745,"amount":3157.0853,"timestamp":1765579722613},"delay":0,"floatShares":23879000,"shares":23987600,"eps":-0.701259,"marketStatus":"休市中","change":-0.0015,"latestTime":"12-12 16:00:00 EST","open":0.3,"high":0.3048,"low":0.2931,"amount":79826.8072174,"amplitude":0.039381,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.701259,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1532664000000,"exchange":"NASDAQ","adjPreClose":0.2971,"preHourTrading":{"tag":"盘前","latestPrice":0.2999,"preClose":0.2971,"latestTime":"09:25 EST","volume":3976,"amount":1189.5305352,"timestamp":1765549531691},"postHourTrading":{"tag":"盘后","latestPrice":0.2941,"preClose":0.2956,"latestTime":"17:48 EST","volume":10745,"amount":3157.0853,"timestamp":1765579722613},"volumeRatio":1.3953715456747773,"impliedVol":1.6275,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ADIL/wiki","defaultTab":"wiki","newsList":[{"id":"1173173688","title":"Adial Pharmaceuticals 宣布进行一项约 286 万美元的认股权证诱导交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1173173688","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173173688?lang=zh_cn&edition=full","pubTime":"2025-11-26 21:01","pubTimestamp":1764162098,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals 宣布进行一项约 286 万美元的认股权证诱导交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"1144051693","title":"Adial Pharmaceuticals: 根据Eop2会议实施FDA的建议,推动Ad04进入3期开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1144051693","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144051693?lang=zh_cn&edition=full","pubTime":"2025-11-14 21:51","pubTimestamp":1763128263,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals: 根据Eop2会议实施FDA的建议,推动Ad04进入3期开发","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"1165269421","title":"Adial Pharmaceuticals在FDA二期临床试验结束会议获得积极反馈后发布AD04项目业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1165269421","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165269421?lang=zh_cn&edition=full","pubTime":"2025-09-16 20:01","pubTimestamp":1758024114,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals在FDA二期临床试验结束会议获得积极反馈后发布AD04项目业务更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2567429180","title":"Adial Pharmaceuticals, Inc盘中异动 股价大涨6.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567429180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567429180?lang=zh_cn&edition=full","pubTime":"2025-09-13 00:58","pubTimestamp":1757696325,"startTime":"0","endTime":"0","summary":"北京时间2025年09月13日00时58分,Adial Pharmaceuticals, Inc股票出现异动,股价急速上涨6.66%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中,整体跌幅为0.64%。其相关个股中,Hcw Biologics Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Yd Bio Ltd C/Wts 28/08/2030涨幅较大,Hcw Biologics Inc.、Cocrystal Pharma, Inc.、Polyrizon Ltd.较为活跃,换手率分别为802.03%、776.74%、636.66%,振幅较大的相关个股有Cocrystal Pharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Ethzilla Corporation C/Wts 06/11/2025,振幅分别为78.47%、38.94%、37.30%。Adial Pharmaceuticals, Inc公司简介:Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250913005845978db811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250913005845978db811&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"1105888236","title":"Adial Pharmaceuticals获纳斯达克180个日历日延期 以重新符合最低买入价规则","url":"https://stock-news.laohu8.com/highlight/detail?id=1105888236","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105888236?lang=zh_cn&edition=full","pubTime":"2025-09-03 20:31","pubTimestamp":1756902674,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals获纳斯达克180个日历日延期 以重新符合最低买入价规则","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2559091816","title":"Adial Pharmaceuticals, Inc盘中异动 早盘股价大跌5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559091816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559091816?lang=zh_cn&edition=full","pubTime":"2025-08-14 21:34","pubTimestamp":1755178497,"startTime":"0","endTime":"0","summary":"北京时间2025年08月14日21时34分,Adial Pharmaceuticals, Inc股票出现波动,股价快速下跌5.90%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中,整体跌幅为0.34%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Codexis, Inc.、天演药业涨幅较大,Scinai Immunotherapeutics Ltd、Tnf Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为73.05%、34.08%、16.28%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Codexis, Inc.、Traws Pharma, Inc.,振幅分别为20.48%、18.74%、14.62%。Adial Pharmaceuticals, Inc公司简介:Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081421345894e38266&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081421345894e38266&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2558575446","title":"Adial Pharmaceuticals, Inc盘中异动 大幅下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558575446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558575446?lang=zh_cn&edition=full","pubTime":"2025-08-08 23:39","pubTimestamp":1754667566,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日23时39分,Adial Pharmaceuticals, Inc股票出现异动,股价快速下挫5.17%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中,整体跌幅为0.79%。其相关个股中,Alector, Inc.、Bioxcel Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃,换手率分别为564.77%、147.09%、99.77%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts ,振幅分别为73.00%、62.10%、44.44%。Adial Pharmaceuticals, Inc公司简介:Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808233927a6db4eeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808233927a6db4eeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2557569305","title":"Adial Pharmaceuticals, Inc盘中异动 早盘大幅下挫5.01%报0.392美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557569305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557569305?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:31","pubTimestamp":1754573481,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时31分,Adial Pharmaceuticals, Inc股票出现异动,股价急速跳水5.01%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中,整体跌幅为0.12%。其相关个股中,Palisade Bio, Inc.、Niagen Bioscience, Inc.、Sarepta Therapeutics, Inc.涨幅较大,Palisade Bio, Inc.、Processa Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为341.71%、61.87%、20.59%,振幅较大的相关个股有Palisade Bio, Inc.、Xeris制药、Q32 Bio Inc.,振幅分别为14.00%、12.75%、9.21%。Adial Pharmaceuticals, Inc公司简介:Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213121a6d8f951&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213121a6d8f951&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2557431693","title":"Adial Pharmaceuticals, Inc盘中异动 下午盘股价大涨5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557431693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557431693?lang=zh_cn&edition=full","pubTime":"2025-08-06 01:50","pubTimestamp":1754416230,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日01时50分,Adial Pharmaceuticals, Inc股票出现异动,股价急速上涨5.87%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中,整体跌幅为3.70%。Adial Pharmaceuticals, Inc公司简介:Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。该公司开发用于治疗成瘾和相关疾病的处方药,其主导产品是AD04,用于治疗饮酒障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508060150309735c491&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508060150309735c491&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2556838750","title":"Adial Pharmaceuticals, Inc盘中异动 早盘股价大跌9.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556838750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556838750?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:31","pubTimestamp":1754314318,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时31分,Adial Pharmaceuticals, Inc股票出现波动,股价大幅下挫9.91%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,Psyence Biomedical Ltd.、Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为2176.53%、789.44%、383.83%,振幅较大的相关个股有Psyence Biomedical Ltd.、凯信远达、Bioxcel Therapeutics, Inc.,振幅分别为20.97%、15.35%、13.50%。Adial Pharmaceuticals, Inc公司简介:Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213159a6d28300&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213159a6d28300&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2555839799","title":"Adial Pharmaceuticals, Inc盘中异动 早盘急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555839799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555839799?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:37","pubTimestamp":1753969078,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时37分,Adial Pharmaceuticals, Inc股票出现异动,股价急速跳水5.06%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中,整体涨幅为2.24%。Adial Pharmaceuticals, Inc公司简介:Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。该公司开发用于治疗成瘾和相关疾病的处方药,其主导产品是AD04,用于治疗饮酒障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073121375894c6645e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073121375894c6645e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2555805491","title":"Adial Pharmaceuticals, Inc股价上涨11.21% 市值涨123.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555805491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555805491?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:32","pubTimestamp":1753795949,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时32分,Adial Pharmaceuticals, Inc股票出现波动,股价大幅拉升11.21%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,Calidi Biotherapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Scinai Immunotherapeutics Ltd涨幅较大,Scinai Immunotherapeutics Ltd、Tnf Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为2452.27%、1139.83%、297.11%,振幅较大的相关个股有Tnf Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.、Scinai Immunotherapeutics Ltd,振幅分别为18.24%、18.20%、18.05%。Adial Pharmaceuticals, Inc公司简介:Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213229a469c7ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213229a469c7ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2554721827","title":"Adial Pharmaceuticals, Inc盘中异动 股价大涨20.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554721827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554721827?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:32","pubTimestamp":1753709524,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时32分,Adial Pharmaceuticals, Inc股票出现异动,股价大幅拉升20.58%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中,整体涨幅为0.15%。其相关个股中,Celcuity Inc.、Aim Immunotech Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大,Aim Immunotech Inc.、Cervomed Inc.、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为222.64%、81.38%、81.17%,振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Lexaria Bioscience Corp.,振幅分别为35.83%、23.86%、10.21%。Adial Pharmaceuticals, Inc公司简介:Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213204a6c61588&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213204a6c61588&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2553735224","title":"Adial Pharmaceuticals, Inc7月23日成交额为57.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553735224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553735224?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:15","pubTimestamp":1753319740,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日,Adial Pharmaceuticals, Inc成交额为57.38万美元,成交额较昨日减少65.80%,当日成交量为120.60万股。Adial Pharmaceuticals, Inc于2025年7月23日涨1.74%,报0.479美元,该股过去5个交易日涨18.2%,年初至今跌52.6%,过去60日跌30.12%。该公司开发用于治疗成瘾和相关疾病的处方药,其主导产品是AD04,用于治疗饮酒障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724091550a6be7bd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724091550a6be7bd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2552482148","title":"Adial Pharmaceuticals, Inc盘中异动 快速拉升5.04%报0.425美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552482148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552482148?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:42","pubTimestamp":1752759745,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时42分,Adial Pharmaceuticals, Inc股票出现波动,股价大幅拉升5.04%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中,整体涨幅为0.29%。Adial Pharmaceuticals, Inc公司简介:Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。该公司开发用于治疗成瘾和相关疾病的处方药,其主导产品是AD04,用于治疗饮酒障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214225a4514446&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214225a4514446&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2551411319","title":"Adial Pharmaceuticals, Inc7月15日成交额为22.28万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551411319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551411319?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:15","pubTimestamp":1752628538,"startTime":"0","endTime":"0","summary":"美东时间2025年7月15日,Adial Pharmaceuticals, Inc成交额为22.28万美元,成交额较昨日减少58.60%,当日成交量为61.30万股。Adial Pharmaceuticals, Inc于2025年7月15日跌0.33%,报0.368美元,该股过去5个交易日涨15.72%,年初至今跌63.56%,过去60日跌48.68%。该公司开发用于治疗成瘾和相关疾病的处方药,其主导产品是AD04,用于治疗饮酒障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716091551a44d69bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716091551a44d69bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2551614184","title":"Adial Pharmaceuticals, Inc盘中异动 股价大跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551614184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551614184?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:43","pubTimestamp":1752500627,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时43分,Adial Pharmaceuticals, Inc股票出现异动,股价大幅下挫5.61%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大,Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃,换手率分别为1675.95%、573.61%、433.39%,振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.,振幅分别为112.70%、100.99%、79.50%。Adial Pharmaceuticals, Inc公司简介:Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421434897a5bfb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421434897a5bfb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2550995912","title":"Adial Pharmaceuticals, Inc盘中异动 大幅下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550995912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550995912?lang=zh_cn&edition=full","pubTime":"2025-07-11 21:32","pubTimestamp":1752240774,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日21时32分,Adial Pharmaceuticals, Inc股票出现波动,股价大幅跳水5.12%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中,整体跌幅为0.63%。其相关个股中,Mink Therapeutics, Inc.、Cel-Sci Corporation、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大,Mink Therapeutics, Inc.、Cel-Sci Corporation、Dare Bioscience, Inc.较为活跃,换手率分别为174.50%、122.85%、73.82%,振幅较大的相关个股有Mink Therapeutics, Inc.、Cel-Sci Corporation、Jupiter Neurosciences, Inc.,振幅分别为34.93%、24.35%、14.66%。Adial Pharmaceuticals, Inc公司简介:Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711213254953ed5f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711213254953ed5f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2550608126","title":"Adial Pharmaceuticals, Inc7月10日成交额为243.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550608126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550608126?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:15","pubTimestamp":1752196539,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日,Adial Pharmaceuticals, Inc成交额为243.63万美元,成交额较昨日增加342.54%,当日成交量为663.43万股。Adial Pharmaceuticals, Inc于2025年7月10日涨28.61%,报0.41美元,该股过去5个交易日涨24.24%,年初至今跌59.41%,过去60日跌42.25%。该公司开发用于治疗成瘾和相关疾病的处方药,其主导产品是AD04,用于治疗饮酒障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091552a6a28e8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091552a6a28e8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2550667199","title":"Adial Pharmaceuticals, Inc7月9日成交额为55.05万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550667199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550667199?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:15","pubTimestamp":1752110137,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日,Adial Pharmaceuticals, Inc成交额为55.05万美元,成交额较昨日增加12.66%,当日成交量为171.85万股。Adial Pharmaceuticals, Inc于2025年7月9日涨0.25%,报0.319美元,该股过去5个交易日涨0.89%,年初至今跌68.44%,过去60日跌55.41%。该公司开发用于治疗成瘾和相关疾病的处方药,其主导产品是AD04,用于治疗饮酒障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710091547a441545a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710091547a441545a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adialpharma.com","stockEarnings":[{"period":"1week","weight":-0.0421},{"period":"1month","weight":-0.1012},{"period":"3month","weight":-0.1554},{"period":"6month","weight":-0.1557},{"period":"1year","weight":-0.7288},{"period":"ytd","weight":-0.7073}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adial Pharmaceuticals, Inc.于2010年11月成立为弗吉尼亚有限责任公司。该公司是一家临床阶段的生物制药公司,专注于开发治疗或预防成瘾和相关疾病的疗法。该公司的研究性新药候选药物AD04正在开发中,作为一种治疗剂,用于治疗酒精使用障碍(“AUD”)。AD04最近在一项3期临床试验中进行了研究,指定为ONWARD试验,用于对具有某些目标基因型的受试者进行AUD的潜在治疗,这些目标基因型是使用伴随诊断基因测试确定的。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.071809},{"month":2,"riseRate":0.285714,"avgChangeRate":0.038631},{"month":3,"riseRate":0,"avgChangeRate":-0.135985},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.019179},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.082775},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.158497},{"month":7,"riseRate":0.571429,"avgChangeRate":0.080123},{"month":8,"riseRate":0.125,"avgChangeRate":-0.073571},{"month":9,"riseRate":0.375,"avgChangeRate":-0.037962},{"month":10,"riseRate":0.25,"avgChangeRate":-0.152838},{"month":11,"riseRate":0.375,"avgChangeRate":0.139286},{"month":12,"riseRate":0.375,"avgChangeRate":0.036843}],"exchange":"NASDAQ","name":"Adial Pharmaceuticals","nameEN":"Adial Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adial Pharmaceuticals(ADIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adial Pharmaceuticals(ADIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adial Pharmaceuticals,ADIL,Adial Pharmaceuticals股票,Adial Pharmaceuticals股票老虎,Adial Pharmaceuticals股票老虎国际,Adial Pharmaceuticals行情,Adial Pharmaceuticals股票行情,Adial Pharmaceuticals股价,Adial Pharmaceuticals股市,Adial Pharmaceuticals股票价格,Adial Pharmaceuticals股票交易,Adial Pharmaceuticals股票购买,Adial Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adial Pharmaceuticals(ADIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adial Pharmaceuticals(ADIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}